BACKGROUND: Among male injection drug users (IDUs) in Tijuana, Mexico, U.S. deportation is associated with HIV transmission. Changing drug use behaviors following deportation, including the use of new drugs, may increase HIV risk but are understudied. We identify correlates of trying new drugs following male IDUs' most recent U.S. deportation to Mexico. METHODS: In 2010, we recruited 328 deported male IDUs in Tijuana, Mexico. Questionnaires collected retrospective data on drug use and other HIV risk behaviors throughout migratory events. Logistic regression identified correlates of trying new drugs/combinations following their most recent deportations. Informed consent was obtained from all participants. RESULTS: Nearly one in six men (n=52, 16%) tried new drugs following their most recent deportation, including heroin (n=31), methamphetamine (n=5), and heroin/methamphetamine combined (n=17). Trying new drugs following deportation was independently associated with U.S. incarceration (adjusted odds ratio [AOR]=3.96; 95% confidence interval [C.I.] 1.78, 8.84), increasing numbers of U.S. deportations (AOR=1.11 per deportation; C.I. 1.03, 1.20), feeling sad following deportation (AOR 2.69; C.I. 1.41, 5.14), and perceiving that one's current lifestyle increases HIV/AIDS risk (AOR 3.91; C.I. 2.05, 7.44). CONCLUSIONS: Trying new drugs following U.S. deportation may be related to the unique contexts and stressors experienced by drug-abusing migrants as they attempt to reestablish their lives in Mexico. Findings imply an unmet need for health and social programs to alleviate pre- and post-deportation stressors faced by undocumented and return migrants in the U.S.-Mexico context.
BACKGROUND: Among male injection drug users (IDUs) in Tijuana, Mexico, U.S. deportation is associated with HIV transmission. Changing drug use behaviors following deportation, including the use of new drugs, may increase HIV risk but are understudied. We identify correlates of trying new drugs following male IDUs' most recent U.S. deportation to Mexico. METHODS: In 2010, we recruited 328 deported male IDUs in Tijuana, Mexico. Questionnaires collected retrospective data on drug use and other HIV risk behaviors throughout migratory events. Logistic regression identified correlates of trying new drugs/combinations following their most recent deportations. Informed consent was obtained from all participants. RESULTS: Nearly one in six men (n=52, 16%) tried new drugs following their most recent deportation, including heroin (n=31), methamphetamine (n=5), and heroin/methamphetamine combined (n=17). Trying new drugs following deportation was independently associated with U.S. incarceration (adjusted odds ratio [AOR]=3.96; 95% confidence interval [C.I.] 1.78, 8.84), increasing numbers of U.S. deportations (AOR=1.11 per deportation; C.I. 1.03, 1.20), feeling sad following deportation (AOR 2.69; C.I. 1.41, 5.14), and perceiving that one's current lifestyle increases HIV/AIDS risk (AOR 3.91; C.I. 2.05, 7.44). CONCLUSIONS: Trying new drugs following U.S. deportation may be related to the unique contexts and stressors experienced by drug-abusing migrants as they attempt to reestablish their lives in Mexico. Findings imply an unmet need for health and social programs to alleviate pre- and post-deportation stressors faced by undocumented and return migrants in the U.S.-Mexico context.
Authors: Louisa Degenhardt; Bradley Mathers; Mauro Guarinieri; Samiran Panda; Benjamin Phillips; Steffanie A Strathdee; Mark Tyndall; Lucas Wiessing; Alex Wodak; John Howard Journal: Int J Drug Policy Date: 2010-02-01
Authors: Becky L Genberg; Stephen J Gange; Vivian F Go; David D Celentano; Gregory D Kirk; Carl A Latkin; Shruti H Mehta Journal: Addiction Date: 2011-07-27 Impact factor: 6.526
Authors: Steffanie A Strathdee; Remedios Lozada; Robin A Pollini; Kimberly C Brouwer; Andrea Mantsios; Daniela A Abramovitz; Tim Rhodes; Carl A Latkin; Oralia Loza; Jorge Alvelais; Carlos Magis-Rodriguez; Thomas L Patterson Journal: J Acquir Immune Defic Syndr Date: 2008-03-01 Impact factor: 3.731
Authors: Steffanie A Strathdee; Carlos Magis-Rodriguez; Vickie M Mays; Richard Jimenez; Thomas L Patterson Journal: Ann Epidemiol Date: 2012-06 Impact factor: 3.797
Authors: Miguel Pinedo; José Luis Burgos; Angela M Robertson; Alicia Vera; Remedios Lozada; Victoria D Ojeda Journal: Glob Public Health Date: 2014-03-21
Authors: Natalie Ferraiolo; Miguel Pinedo; Jessica McCurley; Jose Luis Burgos; Adriana Carolina Vargas-Ojeda; Michael A Rodriguez; Victoria D Ojeda Journal: Int J Cult Ment Health Date: 2016-03-10
Authors: Camila Gelpí-Acosta; Enrique R Pouget; Kathleen H Reilly; Holly Hagan; Alan Neaigus; Travis Wendel; David M Marshall Journal: Subst Use Misuse Date: 2016-04-21 Impact factor: 2.164
Authors: David Goodman-Meza; Maria Elena Medina-Mora; Carlos Magis-Rodríguez; Raphael J Landovitz; Steve Shoptaw; Dan Werb Journal: Am J Public Health Date: 2018-11-29 Impact factor: 9.308
Authors: A Bórquez; R S Garfein; D Abramovitz; L Liu; L Beletsky; D Werb; S R Mehta; G Rangel; C Magis-Rodríguez; P González-Zúñiga; S A Strathdee Journal: J Immigr Minor Health Date: 2019-12
Authors: Xiao Zhang; Ana P Martinez-Donate; Jenna Nobles; Melbourne F Hovell; Maria Gudelia Rangel; Natalie M Rhoads Journal: J Immigr Minor Health Date: 2015-12
Authors: Miguel Pinedo; José Luis Burgos; María Luisa Zúñiga; Ramona Perez; Caroline A Macera; Victoria D Ojeda Journal: Glob Public Health Date: 2016-04-30